phenytoin has been researched along with cyclosporine in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 30 (37.04) | 18.2507 |
2000's | 25 (30.86) | 29.6817 |
2010's | 24 (29.63) | 24.3611 |
2020's | 2 (2.47) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Baltes, S; Fedrowitz, M; Gastens, AM; Kaever, V; Löscher, W; Potschka, H | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Helaiel, EH; Lashin, AN; Sobhi, MA | 1 |
Bernimoulin, JP; Hinz, N; Romanos, GE; Schröter-Kermani, C | 1 |
Bigler, S; Hänseler, E; Wad, N | 1 |
Carey, D; Lee, HS; Tett, S | 1 |
Chowdhury, MH; Dempster, DW; Hamada, C | 1 |
Hannak, V; Herrmann, D | 1 |
Ellis, JS; Seymour, RA; Thomason, JM | 2 |
Levine, RA; Rees, TD | 1 |
Seymour, RA | 1 |
Dongari, A; Langlais, RP; McDonnell, HT | 1 |
Hortin, GL; Landt, M; Smith, CH | 1 |
Tanira, MO; Wasfi, IA | 1 |
Bernimoulin, JP; Romanos, GE; Strub, JR | 1 |
Eisen, D | 1 |
Akalin, FA; Bozkurt, FY; Eratalay, K; Kalfa, Z; Renda, N; Sengün, D; Velidedeoglu, E | 1 |
Bakatselou, V; Dressman, JB; Mithani, SD; TenHoor, CN | 1 |
Ishida, H; Morisaki, I; Nagata, T; Nishikawa, S; Oka, T | 1 |
Berini, L; Brunet, L; Farré, M; Mendieta, C; Miranda, J | 1 |
Cutler, CW; Dill, RE; Doxey, D; Fojt, J; Gonzales, A; Iacopino, AM; Nares, S; Stoever, K | 1 |
Chaushu, G; Givol, N; Katz, J; Shemer, J; Taicher, S | 1 |
Blankenau, R; Keene, JJ; Mattson, JS | 1 |
Botha, PJ | 1 |
Desai, P; Silver, JG | 1 |
Hall, EE | 1 |
Chosidow, O; Cribier, B | 1 |
Broccoletti, R; Carbone, M; Carrozzo, M; Gandolfo, S; Garzino-Demo, P | 1 |
Meraw, SJ; Sheridan, PJ | 1 |
Dongari-Bagtzoglou, AI; Morton, RS | 1 |
Bartold, PM; Marshall, RI | 1 |
Albright, GM; Chou, HH; Iacopino, AM; Murayama, Y; Nares, S; Naruishi, K; Nishimura, F; Takashiba, S; Yamada, H | 1 |
Arriba, L; de Andrés, A; Hernández, G; Lucas, M | 1 |
Firatli, E; Hong, HH; Kantarci, A; Sheff, MC; Trackman, PC; Uygur, C; Uzel, MI | 1 |
Beattie, TJ; Hodges, CB; Jindal, RM; Maxwell, H; Murphy, AV | 1 |
Taylor, BA | 1 |
Nghiem, DD | 1 |
Echizen, H; Kanamori, M; Takahashi, H | 1 |
Harman, KE; Higgins, EM; Morris, SD | 1 |
Agarwal, SK; Garg, D; Kubba, S; Makhija, A; Pathania, A; Prakash, A; Prakash, N; Singh, NP | 1 |
Jaiarj, N | 1 |
Kantarci, A; Trackman, PC | 1 |
Evans, CG; Formea, CM; Karlix, JL | 1 |
Avilés Izquierdo, J; Chavarria Mur, E; García Sánchez, I; Gilsanz Fernández, C; Molina Sánchez-Cabezudo, F; Vera López, E | 1 |
Buduneli, E; Buduneli, N; Cinar, S; Kinane, DF; Lappin, D | 1 |
Augustin, P; Firatli, E; Graves, DT; Hasturk, H; Kantarci, A; Sheff, MC; Trackman, PC | 1 |
Castro, AL; Crivelini, MM; Garcia, JF; Kanno, CM; Oliveira, JA | 1 |
Liu, HY; Liu, X; Liu, XD; Liu, YC; Wang, GJ; Xie, L; Yang, HW; Zhang, DM | 1 |
Bhattacharyya, I; Cohen, D | 1 |
Blanchet, B; Jullien, V; Tod, M; Vinsonneau, C | 1 |
Hara, Y; Kaneko, T; Ozaki, Y; Suzuki, AM; Yoshimura, A | 1 |
Danjo, K; Niwa, T; Shimabara, H | 1 |
Kantarci, A; Kim, YS; Nseir, Z; Sume, SS; Trackman, PC | 1 |
Ashrafi, SS; Nakib, N | 1 |
Aarabi, M; Allabi, AC; Almond, LM; Ghobadi, C; Jamei, M; Johnson, TN; Rostami-Hodjegan, A; Rowland-Yeo, K | 1 |
Bagheri, H; Bondon-Guitton, E; Montastruc, JL | 1 |
Bush, ED; Fabian, E; Herold, M; Kamp, HG; Krennrich, G; Looser, R; Mattes, WB; Mellert, W; Moeller, N; Nadanaciva, S; Naraoka, H; Omura, K; Piccoli, SP; Prokoudine, A; Ruiz-Noppinger, P; Schuppe-Koistinen, I; Strauss, V; van Ravenzwaay, B; Walk, T | 1 |
Namdari, M; Rezazadeh, F; Salman, BN; Vahabi, S | 1 |
Abdul-Rahman, M; Al-Hamilly, NS; Grawish, ME; Mourad, MI; Radwan, LR | 1 |
Bartold, PM; Hughes, FJ | 1 |
Bian, Z; Fang, YJ; Meng, LY; Tay, FR; Zhao, XH | 1 |
Ervolino, E; Kanno, CM; Oliveira, JA; Soubhia, AMP | 1 |
Song, J; Wang, X; Wu, J; Zhang, R; Zhu, J | 1 |
25 review(s) available for phenytoin and cyclosporine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced gingival overgrowth and its management.
Topics: Calcium Channel Blockers; Cyclosporine; Gingival Hypertrophy; Humans; Phenytoin | 1993 |
Systematic drugs as a risk factor for periodontal disease initiation and progression.
Topics: Calcium Channel Blockers; Cyclosporine; Female; Fibromatosis, Gingival; Gingival Hyperplasia; Gonadal Steroid Hormones; Humans; Male; Nifedipine; Phenytoin | 1995 |
Drug-induced gingival overgrowth.
Topics: Animals; Calcium Channel Blockers; Cyclosporine; Folic Acid; Gingiva; Humans; Phenytoin | 1993 |
Drug-induced gingival overgrowth.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Hypertrophy; Humans; Phenytoin | 1993 |
The therapy of oral lichen planus.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Candidiasis, Oral; Cryosurgery; Cyclosporine; Humans; Lichen Planus; Mouth Diseases; Mouth Mucosa; Phenytoin; PUVA Therapy; Retinoids | 1993 |
The pathogenesis of drug-induced gingival overgrowth.
Topics: Adult; Age Factors; Anticonvulsants; Calcium Channel Blockers; Child; Cyclosporine; Dental Plaque; Fibroblasts; Gingiva; Gingival Hyperplasia; Gingivitis; Growth Substances; Humans; Immunosuppressive Agents; Phenytoin | 1996 |
Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model.
Topics: Age Factors; Animals; Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Dental Plaque; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Gingival Hyperplasia; Gingivitis; Humans; Immunosuppressive Agents; Male; Nifedipine; Phenytoin; Rats; Rats, Inbred F344; Sex Factors; Specific Pathogen-Free Organisms | 1996 |
Gingival enlargement induced by drugs.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin | 1996 |
Drug-induced gingival hyperplasia and its management--a literature review.
Topics: Anticonvulsants; Calcium Channel Blockers; Clinical Protocols; Cyclosporine; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin | 1997 |
Drug-induced gingival enlargements.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Overgrowth; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin; Verapamil | 1998 |
Prevention and treatment considerations in patients with drug-induced gingival enlargement.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Dental Prophylaxis; Gingival Overgrowth; Gingivectomy; Humans; Immunosuppressive Agents; Nifedipine; Oral Hygiene; Phenytoin | 1997 |
[Lichen].
Topics: Adrenal Cortex Hormones; Cyclosporine; Dapsone; Griseofulvin; Humans; Immunosuppressive Agents; Lichen Planus; Metronidazole; Phenytoin; PUVA Therapy; Retinoids | 1997 |
[An increase in gingival volume induced by drugs (phenytoin, cyclosporine and calcium antagonists). A review of the literature].
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Overgrowth; Humans; Immunosuppressive Agents; Phenytoin | 1998 |
Medically induced gingival hyperplasia.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Phenytoin | 1998 |
A clinical review of drug-induced gingival overgrowths.
Topics: Anticonvulsants; Australia; Calcium Channel Blockers; Cyclosporine; Drug Interactions; Gingival Overgrowth; Humans; Immunosuppressive Agents; Oral Hygiene; Phenytoin | 1999 |
Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus.
Topics: Anticonvulsants; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Epilepsy; Female; Gingival Overgrowth; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Phenytoin; Tacrolimus; Time Factors | 2000 |
Drug-induced gingival overgrowth.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Phenytoin | 2003 |
Connective tissue metabolism and gingival overgrowth.
Topics: Animals; Anticonvulsants; Antihypertensive Agents; Connective Tissue; Connective Tissue Growth Factor; Cyclosporine; Extracellular Matrix; Fibroblasts; Gingival Overgrowth; Growth Substances; Humans; Immediate-Early Proteins; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Nifedipine; Phagocytosis; Phenytoin | 2004 |
Altered cytochrome p450 metabolism of calcineurin inhibitors: case report and review of the literature.
Topics: Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Cytochrome P-450 CYP3A; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Oxidoreductases, N-Demethylating; Phenytoin; Tacrolimus | 2005 |
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
Topics: Analgesics; Anesthetics; Animals; Anti-Infective Agents; Anti-Ulcer Agents; Anticonvulsants; Burns; Cyclosporine; Drug Administration Schedule; Humans; Immunosuppressive Agents; Neuromuscular Nondepolarizing Agents; Phenytoin | 2008 |
Drug-induced gingival overgrowth.
Topics: Adult; Anticonvulsants; Calcium Channel Blockers; Child; Cyclosporine; Gingiva; Gingival Overgrowth; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin; Prevalence; Risk Factors | 2011 |
Periodontal complications of prescription and recreational drugs.
Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Calcium Channel Blockers; Cannabis; Contraceptives, Oral; Cyclosporine; Diphosphonates; Gingiva; Gingival Overgrowth; Hallucinogens; Hormone Replacement Therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Illicit Drugs; Immunosuppressive Agents; Inflammation; Methadone; Periodontal Diseases; Periodontal Index; Periodontium; Phenytoin; Platelet Aggregation Inhibitors; Tropanes | 2018 |
Drug-induced excess hair growth.
Topics: Adrenal Cortex Hormones; Androgens; Anticonvulsants; Cyclosporine; Dinoprost; ErbB Receptors; Hirsutism; Humans; Hypertrichosis; Immunosuppressive Agents; Minoxidil; Oxytocics; Phenytoin; Protein Kinase Inhibitors; Vasodilator Agents | 2017 |
Bibliometric analysis of research trends and characteristics of drug-induced gingival overgrowth.
Topics: Amlodipine; Anticonvulsants; Bibliometrics; Calcium Channel Blockers; Cyclosporine; Gingival Overgrowth; Humans; Immunosuppressive Agents; Nifedipine; Phenytoin | 2022 |
1 trial(s) available for phenytoin and cyclosporine
Article | Year |
---|---|
Analyses of the pattern of therapeutic drug monitoring in a university hospital laboratory. Suitability and performance of the CEDIA assays.
Topics: Carbamazepine; Chromatography, High Pressure Liquid; Cyclosporine; Digoxin; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy; Humans; Immunoenzyme Techniques; Pharmacokinetics; Phenobarbital; Phenytoin; Quality Control; Theophylline | 1992 |
55 other study(ies) available for phenytoin and cyclosporine
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
Topics: Analysis of Variance; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Carbamazepine; Cell Line; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression; Humans; Levetiracetam; Mice; Phenytoin; Piracetam; Transfection | 2007 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparative study of ultrastructural changes of the gingival hyperplasia induced by cyclosporine and dilantin.
Topics: Adult; Cyclosporine; Gingiva; Gingival Hyperplasia; Humans; Microscopy, Electron; Middle Aged; Phenytoin | 1992 |
Distribution of fibronectin in healthy, inflamed and drug-induced gingival hyperplasia.
Topics: Actin Cytoskeleton; Adult; Connective Tissue; Connective Tissue Cells; Cyclosporine; Dental Plaque; Epithelium; Female; Fibronectins; Fluorescent Antibody Technique; Gingiva; Gingival Hemorrhage; Gingival Hyperplasia; Gingival Pocket; Gingivitis; Humans; Male; Middle Aged; Nifedipine; Phenytoin | 1992 |
Drug interactions with fluconazole.
Topics: Cross-Sectional Studies; Cyclosporine; Drug Interactions; Fluconazole; Humans; Phenytoin; Theophylline; Warfarin | 1992 |
Effects of heparin on osteoclast activity.
Topics: Animals; Bone Resorption; Cells, Cultured; Chickens; Chondroitin Sulfates; Culture Media; Cyclosporine; Dextran Sulfate; Heparin; Histamine; Leupeptins; Osteoclasts; Phenytoin; Protamines; Rats | 1992 |
[Periodontal side effects of the immunosuppressant cyclosporin A. Clinical study].
Topics: Adolescent; Adult; Child; Cyclosporine; Female; Gingiva; Gingival Hyperplasia; Humans; Male; Middle Aged; Neovascularization, Pathologic; Phenytoin | 1991 |
Evaluation of evacuated blood-collection tubes: effects of three types of polymeric separators on therapeutic drug-monitoring specimens.
Topics: Acrylic Resins; Blood Specimen Collection; Cell Separation; Cyclosporine; Digoxin; Drug Monitoring; Ethanol; Gentamicins; Humans; Phenobarbital; Phenytoin; Polyesters; Polymers; Silicones; Theophylline | 1993 |
The effect of chronic administration of cyclosporin A on phenytoin pharmacokinetic parameters in the rat.
Topics: Animals; Blood Chemical Analysis; Cyclosporine; Drug Interactions; Injections, Intravenous; Male; Phenytoin; Rats; Rats, Sprague-Dawley | 1993 |
Immunohistochemical distribution of extracellular matrix proteins as a diagnostic parameter in healthy and diseased gingiva.
Topics: Adult; Aged; Collagen; Cyclosporine; Extracellular Matrix Proteins; Female; Fibronectins; Fluorescent Antibody Technique; Gingiva; Gingival Hyperplasia; Gingivitis; Glycoproteins; Humans; Immunohistochemistry; Male; Microscopy, Fluorescence; Middle Aged; Nifedipine; Phenytoin | 1993 |
Hydroxyproline and total protein levels in gingiva from patients treated with phenytoin and cyclosporine-A.
Topics: Adult; Age Factors; Anticonvulsants; Collagen; Cyclosporine; Dental Plaque Index; Female; Gingiva; Gingival Hyperplasia; Humans; Hydroxyproline; Male; Periodontal Index; Phenytoin; Protein Biosynthesis | 1996 |
Estimation of the increase in solubility of drugs as a function of bile salt concentration.
Topics: Bile Acids and Salts; Chemical Phenomena; Chemistry, Physical; Cholagogues and Choleretics; Cyclosporine; Diazepam; Fasting; Food; Griseofulvin; Intestinal Absorption; Models, Chemical; Pentazocine; Phenytoin; Solubility; Steroids; Taurocholic Acid | 1996 |
Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia.
Topics: Adult; Animals; Anticonvulsants; Cells, Cultured; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Gingival Hyperplasia; Humans; Immunophenotyping; Immunosuppressive Agents; Interleukin-1; Macrophages; Middle Aged; Phenytoin; Platelet-Derived Growth Factor; Rats; RNA, Messenger | 1997 |
Vigabatrin-induced gingival overgrowth.
Topics: Adult; Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Epilepsy, Complex Partial; Female; Follow-Up Studies; gamma-Aminobutyric Acid; Gingival Overgrowth; Humans; Immunosuppressive Agents; Phenytoin; Vigabatrin | 1997 |
Case report. Use of an argon laser to treat drug-induced gingival overgrowth.
Topics: Anticonvulsants; Argon; Calcium Channel Blockers; Candidiasis, Oral; Cyclosporine; Denture, Complete; Diabetes Mellitus, Type 1; Gingival Hyperplasia; Gingivectomy; Humans; Immunosuppressive Agents; Kidney Transplantation; Laser Therapy; Male; Middle Aged; Patient Education as Topic; Phenytoin | 1998 |
Regulation of gingival fibroblast interleukin-6 secretion by cyclosporine A.
Topics: Anticonvulsants; Bacteria; Calcium Channel Blockers; Cell Division; Cells, Cultured; Cyclosporine; Down-Regulation; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gingiva; Gingival Overgrowth; Humans; Immunosuppressive Agents; Interleukin-1; Interleukin-6; Nifedipine; Phenytoin; Tumor Necrosis Factor-alpha; Up-Regulation | 1999 |
Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts.
Topics: Anticonvulsants; Cathepsin B; Cathepsin L; Cathepsins; Cell Division; Cells, Cultured; Cyclosporine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Endopeptidases; Enzyme Inhibitors; Enzyme Precursors; Extracellular Matrix; Fibroblasts; Gene Expression Regulation, Enzymologic; Gingiva; Gingival Hyperplasia; Humans; Lysosomes; Matrix Metalloproteinase Inhibitors; Phenytoin; Time Factors; Tissue Inhibitor of Metalloproteinase-1 | 2000 |
Connective tissue growth factor in drug-induced gingival overgrowth.
Topics: Adult; Antibodies; Anticonvulsants; Calcium Channel Blockers; Carrier Proteins; Coloring Agents; Connective Tissue; Connective Tissue Growth Factor; Cyclosporine; Endothelium, Vascular; Epithelium; Female; Fibroblasts; Fibrosis; Gingival Overgrowth; Growth Substances; Humans; Image Processing, Computer-Assisted; Immediate-Early Proteins; Immunoenzyme Techniques; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Leukocytes, Mononuclear; Male; Middle Aged; Mitogens; Neovascularization, Pathologic; Nifedipine; Phenytoin; Platelet Endothelial Cell Adhesion Molecule-1; Statistics, Nonparametric; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Use of rapamycin in a transplant patient who developed cyclosporin neurotoxicity.
Topics: Anticonvulsants; Child; Cyclosporine; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Phenytoin; Seizures; Sirolimus | 2001 |
Management of drug-induced gingival enlargement with orthodontic complications.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Dental Plaque; Esthetics, Dental; Feeding and Eating Disorders; Gingival Hypertrophy; Humans; Immunosuppressive Agents; Malocclusion; Patient Care Planning; Patient Care Team; Phenytoin; Speech Disorders | 2000 |
Role of pharmacologic enhancement of p-450 in cyclosporine overdose.
Topics: Cyclosporine; Cytochrome P-450 Enzyme System; Drug Overdose; Humans; Male; Middle Aged; Phenytoin; Poisoning | 2002 |
Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children.
Topics: Administration, Oral; Adolescent; Age Factors; Aryl Hydrocarbon Hydroxylases; Body Surface Area; Body Weight; Child; Child, Preschool; Cyclosporine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Infant; Infant, Newborn; Liver; Metabolic Clearance Rate; Mixed Function Oxygenases; Models, Biological; Organ Size; Phenytoin; Theophylline | 2002 |
Persistent anticonvulsant hypersensitivity syndrome responding to ciclosporin.
Topics: Adult; Anticonvulsants; Biopsy; Cyclosporine; Dermatologic Agents; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Interleukin-5; Lamotrigine; Phenytoin; Pruritus; Triazines | 2003 |
Aplastic anemia complicating systemic lupus erythematosus: successful management with cyclosporine.
Topics: Adult; Anemia, Aplastic; Cyclophosphamide; Cyclosporine; Female; Humans; Lupus Erythematosus, Systemic; Menorrhagia; Methylprednisolone; Pancytopenia; Phenytoin; Seizures; Treatment Outcome | 2004 |
[Odinophagia and cutaneous lesions in patient with cerebral metastases].
Topics: Aged; Anticonvulsants; Back; Brain Neoplasms; Cyclosporine; Dermis; Epilepsy; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Mouth Mucosa; Necrosis; Phenytoin; Skin Diseases; Stevens-Johnson Syndrome | 2006 |
Immunohistochemical evaluation of Ki-67 expression and apoptosis in cyclosporin A-induced gingival overgrowth.
Topics: Adult; Analysis of Variance; Apoptosis; Calcium Channel Blockers; Case-Control Studies; Cell Proliferation; Cyclosporine; Female; Gingival Overgrowth; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Nick-End Labeling; Ki-67 Antigen; Kidney Transplantation; Male; Mitosis; Nifedipine; Phenytoin; Statistics, Nonparametric | 2007 |
Apoptosis in gingival overgrowth tissues.
Topics: Anticonvulsants; Apoptosis; Calcium Channel Blockers; Case-Control Studies; Caspase 3; Cell Proliferation; Cyclosporine; Fibroblasts; Fibromatosis, Gingival; Forkhead Box Protein O1; Forkhead Transcription Factors; Gingival Overgrowth; Gingivitis; Humans; Immunosuppressive Agents; In Situ Nick-End Labeling; Nifedipine; Phenytoin; Proliferating Cell Nuclear Antigen | 2007 |
Effects of cyclosporin, phenytoin, and nifedipine on the synthesis and degradation of gingival collagen in tufted capuchin monkeys (Cebus apella): histochemical and MMP-1 and -2 and collagen I gene expression analyses.
Topics: Animals; Anticonvulsants; Azo Compounds; Biopsy; Calcium Channel Blockers; Cebus; Collagen; Collagen Type I; Collagen Type IV; Coloring Agents; Cyclosporine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gingiva; Gingival Overgrowth; Gingivitis; Histocytochemistry; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Nifedipine; Phenytoin; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Increased P-glycoprotein function and level after long-term exposure of four antiepileptic drugs to rat brain microvascular endothelial cells in vitro.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Carbamazepine; Cells, Cultured; Cerebral Arteries; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelial Cells; Immunosuppressive Agents; Indicators and Reagents; Microcirculation; Phenobarbital; Phenytoin; Rats; Rhodamine 123; Sodium Channel Blockers; Time; Up-Regulation; Valproic Acid; Verapamil | 2008 |
Case of the month: drug-induced hyperplasia.
Topics: Adult; Cyclosporine; Diagnosis, Differential; Female; Gingival Hyperplasia; Humans; Nifedipine; Phenytoin | 2008 |
Cyclosporin A and phenytoin modulate inflammatory responses.
Topics: Animals; Anticonvulsants; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Cyclosporine; Down-Regulation; Escherichia coli; Female; Fibroblasts; Gingiva; Gingival Overgrowth; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Lipid A; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Middle Aged; Phenytoin; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptors | 2009 |
Novel spray freeze-drying technique using four-fluid nozzle-development of organic solvent system to expand its application to poorly water soluble drugs.
Topics: Acetonitriles; Anticonvulsants; Cyclosporine; Freeze Drying; Immunosuppressive Agents; Particle Size; Pharmaceutical Preparations; Phenytoin; Porosity; Solubility; Water | 2010 |
Loss of basement membrane integrity in human gingival overgrowth.
Topics: Adult; Analysis of Variance; Basement Membrane; Case-Control Studies; Cell Adhesion Molecules; Collagen Type IV; Cyclosporine; Epithelial-Mesenchymal Transition; Female; Gene Expression; Gingival Overgrowth; Humans; Kalinin; Male; Nifedipine; Phenytoin; Statistics, Nonparametric; Young Adult | 2011 |
Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
Topics: Adolescent; Adult; Aged; Benzodiazepines; Body Weights and Measures; Caffeine; Chlorzoxazone; Computer Simulation; Cyclosporine; Female; Gastrointestinal Tract; Humans; Kidney; Liver; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Obesity; Obesity, Morbid; Pharmacokinetics; Phenytoin; Regional Blood Flow; Theophylline; Young Adult | 2011 |
Drug-induced gingival hyperplasia.
Topics: Calcium Channel Blockers; Cyclosporine; Gingival Hyperplasia; Humans; Oral Hygiene; Phenytoin | 2011 |
Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Calcium Channel Blockers; Child; Child, Preschool; Cyclosporine; Databases, Factual; Female; France; Gingival Overgrowth; Humans; Immunosuppressive Agents; Infant; Male; Middle Aged; Pharmacovigilance; Phenytoin; Treatment Outcome; Young Adult | 2012 |
Oral pathology quiz # 75. Case number 4. Systemic medication.
Topics: Anticonvulsants; Cyclosporine; Diagnosis, Differential; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Male; Middle Aged; Nifedipine; Phenytoin; Vasodilator Agents | 2012 |
Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling.
Topics: Animals; Captopril; Cyclosporine; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kidney Diseases; Lisinopril; Male; Metabolome; Metabolomics; Phenytoin; Rats; Rats, Wistar | 2013 |
Effects of cyclosporine and phenytoin on biomarker expressions in gingival fibroblasts of children and adults: an in vitro study.
Topics: Adult; Age Factors; Biomarkers; Cell Culture Techniques; Cells, Cultured; Child; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gene Expression; Gingiva; Gingival Overgrowth; Humans; Phenytoin | 2014 |
Biological roles of KGF, CTGF and TGF-β in cyclosporine-A- and phenytoin- induced gingival overgrowth: A comparative experimental animal study.
Topics: Animals; Connective Tissue Growth Factor; Cyclosporine; Disease Models, Animal; Epithelium; Fibroblast Growth Factor 7; Fibroblasts; Gingiva; Gingival Overgrowth; Male; Phenytoin; Random Allocation; Rats; Transforming Growth Factor beta | 2016 |
Topical application of phenytoin or nifedipine-loaded PLGA microspheres promotes periodontal regeneration in vivo.
Topics: Administration, Topical; Alveolar Bone Loss; Animals; Biomarkers; Cyclosporine; Drug Carriers; Gingival Recession; Immunohistochemistry; Male; Microspheres; Nifedipine; Phenytoin; Polyesters; Random Allocation; Rats; Rats, Sprague-Dawley; Single-Blind Method; X-Ray Microtomography | 2019 |
Effects of cyclosporin, nifedipine and phenytoin on gingival myofibroblast transdifferentiation in monkeys.
Topics: Actins; Animals; Apoptosis; Biopsy; Cell Proliferation; Cell Transdifferentiation; Cyclosporine; Genes, bcl-2; Gingiva; Gingival Overgrowth; Haplorhini; Immunohistochemistry; Ki-67 Antigen; Longitudinal Studies; Male; Myofibroblasts; Nifedipine; Phenytoin; Random Allocation | 2018 |